U.S. markets closed
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • Dow 30

    33,290.08
    -533.37 (-1.58%)
     
  • Nasdaq

    14,030.38
    -130.97 (-0.92%)
     
  • Russell 2000

    2,237.75
    -49.71 (-2.17%)
     
  • Crude Oil

    71.50
    +0.46 (+0.65%)
     
  • Gold

    1,763.90
    -10.90 (-0.61%)
     
  • Silver

    25.84
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1865
    -0.0045 (-0.38%)
     
  • 10-Yr Bond

    1.4500
    -0.0610 (-4.04%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.83%)
     
  • USD/JPY

    110.1500
    -0.0810 (-0.07%)
     
  • BTC-USD

    35,496.04
    -2,244.30 (-5.95%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

Aegis Spine's Attempt to Stay Court Order Halting Sale of Their AccelFix-XT Denied, Life Spine Announces

·2 min read

Life Spine won a second ruling barring Aegis Spine, Inc. from marketing, selling, or distributing devices in its AccelFix-XT product line.

A preliminary injunction preventing Aegis’s marketing and sale of its AccelFix-XT line of expandable medical devices has been in effect since April 5, 2021. Aegis’s attempt to stay the injunction was denied on May 4, 2021.

The United States District Court for the Northern District of Illinois issued the injunction after finding that Aegis and its parent company, L&K Biomed Co., Ltd., used Life Spine’s proprietary PROLIFT® expandable cage to develop the AccelFix-XT. In response to Aegis’ motion to stay the injunction pending its appeal to the Seventh Circuit, the Court reaffirmed its finding that "Life Spine has a high likelihood of success on its [various] claims based on evidence that, among other things, Aegis took calculated steps to help copy or reverse engineer the PROLIFT implant, disclosed Life Spine’s confidential information to third parties, shipped the PROLIFT implant to a third party without Life Spine’s knowledge or permission, and failed to train its employees regarding its contractual confidentiality obligations."

Given the Court’s wholesale rejection of Aegis’s arguments, the injunction preventing Aegis’s marketing and sale of any items in the AccelFix-XT product line remains in effect.

Life Spine’s CEO Michael Butler said of the ruling: "The Court’s ruling validates our claims and we appreciate the thorough analysis of the issues presented. The ruling protects the propriety technology around our PROLIFT Expandable Implants."

About Life Spine

Life Spine is an industry-leading medical device company that specializes in providing innovative, Micro Invasive solutions to address a wide range of spinal pathologies. Life Spine is dedicated to improving the quality of life for patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine is pleased to offer its top-performing PROLIFT® expandable spacer system as part of this mission.

For Full Opinion and Order Visit - https://www.docketalarm.com/cases/Illinois_Northern_District_Court/1--19-cv-07092/Life_Spine_Inc._v._Aegis_Spine_Inc/254/

View source version on businesswire.com: https://www.businesswire.com/news/home/20210506005946/en/

Contacts

Heather Glaser
General Counsel
hglaser@lifespine.com
847-884-6117